{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:59:02Z","timestamp":1793224742886,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011575.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000}}],"reference-count":89,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011575.pub3","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T06:44:14Z","timestamp":1734417854000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Higher blood pressure targets for hypertension in older adults"],"prefix":"10.1002","volume":"2024","author":[{"given":"Jamie M","family":"Falk","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Rady Faculty of Health Sciences; University of Manitoba; Winnipeg Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Froentjes","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica EM","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balraj S","family":"Heran","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Kolber","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Michael","family":"Allan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton Canada"},{"name":"Executive Director & Chief Executive Officer; College of Family Physicians of Canada and The Foundation for Advancing Family Medicine; Mississauga Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S","family":"Korownyk","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R","family":"Garrison","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"10.1002\/14651858.CD011575.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/hr.2010.162","article-title":"Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine: renal subset analysis of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"33","author":"Hayashi","year":"2010","journal-title":"Hypertension Research"},{"issue":"12","key":"10.1002\/14651858.CD011575.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"31","author":"JATOS Study Group","year":"2008","journal-title":"Hypertension Research"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1291\/hypres.28.513","article-title":"The Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months","volume":"28","author":"JATOS Study Group","year":"2005","journal-title":"Hypertension Research"},{"issue":"11","key":"10.1002\/14651858.CD011575.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/ajh.2011.138","article-title":"Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study","volume":"24","author":"Kawano","year":"2011","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/hr.2010.144","article-title":"Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS","volume":"33","author":"Rakugi","year":"2010","journal-title":"Hypertension Research"},{"issue":"9","key":"10.1002\/14651858.CD011575.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1291\/hypres.27.657","article-title":"Valsartan in elderly isolated systolic hypertension (VALISH) study: rationale and design","volume":"27","author":"Ogihara","year":"2004","journal-title":"Hypertension Research"},{"issue":"2","key":"10.1002\/14651858.CD011575.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","article-title":"Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study","volume":"56","author":"Ogihara","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD011575.pub3-BIB0008|cit8","first-page":"A193","article-title":"Intensified antihypertensive therapy and blood pressure variability in older than 70 of Chinese hypertensive patients","volume":"97","author":"Jin","year":"2011","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jch.12094","article-title":"Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years","volume":"15","author":"Wei","year":"2013","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.04.24303756","article-title":"Intensive blood pressure lowering improves left ventricular geometry in older hypertensive patients: the STEP trial","volume":"NA","author":"Deng","year":"2024","journal-title":"MedRxiv: the Preprint Server for Health Sciences"},{"issue":"1","key":"10.1002\/14651858.CD011575.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"e24172","DOI":"10.1002\/clc.24172","article-title":"Effects of intensive blood-pressure treatment on myocardial work in elderly hypertensive patients: a subcenter study of the STEP randomized controlled trial","volume":"47","author":"Feng","year":"2024","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0012|cit12","first-page":"e11","article-title":"Remnant cholesterol and intensive blood pressure control in older patients with hypertension: a post hoc analysis of the step randomized trial","volume":"41","author":"Yang","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD011575.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/HYPERTENSIONAHA.123.21892","article-title":"Influence of baseline diastolic blood pressure on the effects of intensive blood pressure lowering: results from the STEP randomized trial","volume":"80","author":"Yang","year":"2023","journal-title":"Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/eurjpc\/zwae001","article-title":"Remnant cholesterol and intensive blood pressure control in older patients with hypertension: a post hoc analysis of the STEP randomized trial","volume":"31","author":"Yang","year":"2024","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0015|cit15","first-page":"E11","article-title":"The influence of baseline diastolic blood pressure on the effects of intensive blood pressure lowering: results from the step randomized trial","volume":"41","author":"Yang","year":"2023","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"105913","DOI":"10.1016\/j.cct.2019.105913","article-title":"Strategy of blood pressure intervention in the elderly hypertensive patients (STEP): rational, design, and baseline characteristics for the main trial","volume":"89","author":"Zhang","year":"2020","journal-title":"Contemporary Clinical Trials"},{"issue":"14","key":"10.1002\/14651858.CD011575.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011575.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15006-024-3571-6","article-title":"Low diastolic blood pressure in old age not a hindrance to intensive therapy: post hoc analysis of the STEP (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) study","volume":"166","author":"Zidek","year":"2024","journal-title":"MMW \u2212 Fortschritte der Medizin"},{"issue":"16","key":"10.1002\/14651858.CD011575.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e013098","DOI":"10.1161\/JAHA.119.013098","article-title":"Effect of baseline kidney function on the risk of recurrent stroke and on effects of intensive blood pressure control in patients with previous lacunar stroke: a post hoc analysis of the SPS3 trial (Secondary Prevention of Small Subcortical Strokes)","volume":"8","author":"Agarwal","year":"2019","journal-title":"Journal of the American Heart Association"},{"issue":"18","key":"10.1002\/14651858.CD011575.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1001\/jama.2016.14927","article-title":"Intensive vs standard blood pressure control for older adults","volume":"316","author":"Andersson","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/HJH.0000000000002440","article-title":"Functional health and white matter hyperintensities as effect modifiers of blood pressure-lowering on cognitive function and vascular events in older Secondary Prevention of Small Subcortical Strokes trial participants","volume":"38","author":"Blum","year":"2020","journal-title":"Journal of Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.amjmed.2010.02.014","article-title":"Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy","volume":"123","author":"Denardo","year":"2010","journal-title":"American Journal of Medicine"},{"issue":"18","key":"10.1002\/14651858.CD011575.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.2016.14921","article-title":"Intensive vs standard blood pressure control for older adults","volume":"316","author":"Dimitri","year":"2016","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"107443","DOI":"10.1016\/j.cct.2024.107443","article-title":"Preventing cognitive decline by reducing BP target (PCOT): a randomized, pragmatic, multi-health systems clinical trial","volume":"138","author":"Giacona","year":"2024","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/VHRM.S82839","article-title":"Blood pressure control to prevent decline in cognition after stroke","volume":"11","author":"Ihle-Hansen","year":"2015","journal-title":"Vascular Health and Risk Management"},{"issue":"3","key":"10.1002\/14651858.CD011575.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e010091","DOI":"10.1161\/JAHA.118.010091","article-title":"Cerebral white matter hyperintensities, kidney function decline, and recurrent stroke after intensive blood pressure lowering: results from the Secondary Prevention of Small Subcortical Strokes (SPS 3) trial","volume":"8","author":"Ikeme","year":"2019","journal-title":"Journal of the American Heart Association"},{"issue":"18","key":"10.1002\/14651858.CD011575.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/jama.2016.14912","article-title":"Intensive vs standard blood pressure control for older adults","volume":"316","author":"Karayiannis","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD011575.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"e1002538","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Medicine"},{"issue":"18","key":"10.1002\/14651858.CD011575.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.2016.14909","article-title":"Intensive vs standard blood pressure control for older adults","volume":"316","author":"Kim","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD011575.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"e0229483","DOI":"10.1371\/journal.pone.0229483","article-title":"Remote blood pressure monitoring and behavioral intensification for stroke: a randomized controlled feasibility trial","volume":"15","author":"Kim","year":"2018","journal-title":"PloS One"},{"issue":"9","key":"10.1002\/14651858.CD011575.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2018040365","article-title":"Acute declines in renal function during intensive BP lowering and long-term risk of death","volume":"29","author":"Ku","year":"2018","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"10.1002\/14651858.CD011575.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08037051.2017.1382310","article-title":"Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial","volume":"27","author":"Ku","year":"2018","journal-title":"Blood Pressure"},{"issue":"1","key":"10.1002\/14651858.CD011575.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1681\/ASN.2017020135","article-title":"BP in dialysis: results of a pilot study","volume":"29","author":"Miskulin","year":"2018","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0035|cit35","unstructured":"Optimal blood pressure for the prevention of major vascular events in patients with DIABETES mellitus (OPTIMAL-DIABETES) https:\/\/clinicaltrials.gov\/show\/NCT04040634"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1291\/hypres.31.1595","article-title":"The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial","volume":"31","author":"Ogihara","year":"2008","journal-title":"Hypertension Research"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/hr.2008.34","article-title":"Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial","volume":"32","author":"Ogihara","year":"2009","journal-title":"Hypertension Research"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1447-0594.2011.00690.x","article-title":"Practitioner\u2019s trial on the efficacy of antihypertensive treatment in elderly patients with hypertension II (PATE-Hypertension II study) in Japan","volume":"11","author":"Ogihara","year":"2011","journal-title":"Geriatrics & Gerontology International"},{"issue":"e-Suppl 1","key":"10.1002\/14651858.CD011575.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1097\/01.hjh.0000420751.36796.35","article-title":"Optimal blood pressure to prevent cardiovascular events in the elderly high-risk hypertensive patients: subanalysis of the CASE-J Ex study","volume":"30","author":"Ogihara","year":"2012","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/CIA.S88195","article-title":"Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines","volume":"10","author":"Omboni","year":"2015","journal-title":"Clinical Interventions in Aging"},{"issue":"9","key":"10.1002\/14651858.CD011575.pub3-BIB0041|cit41","first-page":"68","article-title":"Intensive blood pressure control lowers rate of CV events and death in the elderly","volume":"116","author":"Rosenberg","year":"2016","journal-title":"American Journal of Nursing"},{"issue":"5","key":"10.1002\/14651858.CD011575.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10641963.2011.577483","article-title":"Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy","volume":"33","author":"Saito","year":"2011","journal-title":"Clinical and Experimental Hypertension"},{"issue":"19 Pt 2","key":"10.1002\/14651858.CD011575.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/01.wnl.0000311447.85948.78","article-title":"Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial","volume":"70","author":"Saxby","year":"2008","journal-title":"Neurology"},{"issue":"22","key":"10.1002\/14651858.CD011575.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011575.pub3-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1024\/1661-8157\/a002281","article-title":"Intensive Blutdruckbehandlung vs. weniger intensive Behandlung","volume":"105","author":"Steurer","year":"2016","journal-title":"Praxis"},{"issue":"12","key":"10.1002\/14651858.CD011575.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr039","article-title":"Is a systolic blood pressure target < 140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial","volume":"32","author":"Zhang","year":"2011","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD011575.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"107289","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107289","article-title":"Effects of intensive blood pressure control on cognitive function in patients with cerebral small vessel disease","volume":"32","author":"Zhao","year":"2023","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0048|cit48","unstructured":"Impact of the reduction in antihypertensive treatment on total mortality in frail subjects with low systolic blood pressure: study in subjects over 80 years living in nursing homes (RETREAT-FRAIL) https:\/\/clinicaltrials.gov\/study\/NCT03453268"},{"issue":"18","key":"10.1002\/14651858.CD011575.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011575.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","article-title":"Hypertension management in older and frailolder patients","volume":"124","author":"Benetos","year":"2019","journal-title":"Circulation Research"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/00325481.1989.11704506","article-title":"Drug interactions in the elderly. How multiple drug use increases risk exponentially","volume":"86","author":"Cadieux","year":"1989","journal-title":"Postgraduate Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003654.pub4","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamainternmed.2022.1657","article-title":"Time to clinical benefit of intensive blood pressure loweringin patients 60 years and older with hypertension: a secondary analysis of randomized clinical trials","volume":"182","author":"Chen","year":"2022","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0054|cit54","first-page":"1","article-title":"Blood pressure targets in adults with hypertension: a clinical practice guideline from the AAFP","volume":"106","author":"Coles","year":"2022","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0055|cit55","unstructured":"Covidence Veritas Health Innovation 2024"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"Vasan","year":"2008","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Dai S Bancej C Bienek A Walsh P Stewart P Wielgosz A 2009 Tracking Heart Disease and Stroke in Canada. Report from the Canadian Chronic Disease Surveillance System Available at www.phac-aspc.gc.ca\/publicat\/2009\/cvd-avc\/index-eng.php","DOI":"10.24095\/hpcdp.29.4.06"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0058|cit58","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.4"},{"issue":"10022","key":"10.1002\/14651858.CD011575.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011575.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organization and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD011575.pub3-BIB0061|cit61","first-page":"832","article-title":"What are the most common conditions in primary care? Systematic review","volume":"64","author":"Finley","year":"2018","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0062|cit62","unstructured":"GRADRpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0064|cit64","unstructured":"Higgins JP Altman DG Sterne JC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). CochraneHandbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0065|cit65","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.4"},{"issue":"3","key":"10.1002\/14651858.CD011575.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1472-8206.2007.00473.x","article-title":"Clinical pharmacology in the geriatric patient","volume":"21","author":"Hilmer","year":"2007","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"23","key":"10.1002\/14651858.CD011575.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"9349","key":"10.1002\/14651858.CD011575.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD011575.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension. Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH)","volume":"41","author":"Brunstr\u00f6m","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000028.pub3","article-title":"Pharmacotherapy for hypertension in the adults 60 years or older","author":"Musini","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0072|cit72","unstructured":"NICE Hypertension in Adults Guideline Committee Hypertension in adults: diagnosis and management; NICE guideline (NG136) Available at https:\/\/www.nice.org.uk\/guidance\/ng136"},{"issue":"15","key":"10.1002\/14651858.CD011575.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archinternmed.2012.2555","article-title":"Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty","volume":"172","author":"Odden","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011575.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/clc.23303","article-title":"Hypertension in older adults: assessment, management, and challenges","volume":"43","author":"Oliveros","year":"2020","journal-title":"Clinical Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"430","DOI":"10.7326\/M16-1785","article-title":"Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011575.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"The Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012572.pub2","article-title":"Withdrawal of antihypertensive drugs in older people","author":"Reeve","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011575.pub3-BIB0079|cit79","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"11","key":"10.1002\/14651858.CD011575.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1532-5415.2012.04203.x","article-title":"High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus study","volume":"60","author":"Sabayan","year":"2012","journal-title":"Journal of the American Geriatric Society"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40266-019-00683-8","article-title":"Going beyond the guidelines in individualising the use of antihypertensive drugs in older patients","volume":"36","author":"Scott","year":"2019","journal-title":"Drugs and Aging"},{"issue":"11","key":"10.1002\/14651858.CD011575.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/M20-3798","article-title":"Synopsis of the 2020 U.S. Department of Veterans Affairs\/U.S. Department of Defense clinical practice guideline: the diagnosis and management of hypertension in the primary care setting","volume":"173","author":"Tschanz","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011575.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","article-title":"Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review","volume":"297","author":"Van Spall","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD011575.pub3-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD011575.pub3-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub5","article-title":"Beta-blockers for hypertension","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011575.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub3","article-title":"First-line drugs for hypertension","author":"Wright","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011575.pub3-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008170.pub2","article-title":"First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension","author":"Xue","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011575.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011575","article-title":"Blood pressure targets for hypertension in older adults","author":"Garrison","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011575.pub3-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011575.pub2","article-title":"Blood pressure targets for hypertension in older adults","author":"Garrison","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:21:16Z","timestamp":1774887676000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011575.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":89,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011575.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}